SCHEMBL20005694

SCHEMBL20005694

C/C=C1\SC(=S)N(c2ccccc2)C1=O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 10/20 0.62
KMT2A Q03164 10/20 0.62
MAPT P10636 8/20 0.59
ALDH1A1 P00352 5/20 0.59
POLB P06746 4/20 0.59
THRB P10828 3/20 0.59
L3MBTL1 Q9Y468 2/20 0.59
MAPK1 P28482 2/20 0.59
KDM4E B2RXH2 1/20 0.59
RECQL P46063 3/20 0.59
RAB9A P51151 4/20 0.56
NPC1 O15118 2/20 0.56
PSMD14 O00487 1/20 0.56
ALPG P10696 1/20 0.56
PKM P14618 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56
TDP1 Q9NUW8 1/20 0.56
DUSP22 Q9NRW4 6/20 0.55
DUSP3 P51452 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13220197 1.00 MEN1 (0.62) MEN1KMT2AMAPTALDH1A1POLB
SCHEMBL13170370 0.83 DUSP22 (0.70) MEN1KMT2AMAPTALDH1A1POLB
SCHEMBL10035996 0.82 DUSP22 (0.77) MEN1KMT2AMAPTALDH1A1POLB
SCHEMBL9917038 0.82 DUSP22 (0.77) MEN1KMT2AMAPTALDH1A1POLB
SCHEMBL12123516 0.82 DUSP22 (0.77) MEN1KMT2AMAPTALDH1A1POLB
SCHEMBL11116026 0.81 MAPT (0.60) MEN1KMT2AMAPTALDH1A1POLB
SCHEMBL13220175 0.78 MEN1 (0.57) MEN1KMT2AMAPTALDH1A1POLB
SCHEMBL14213563 0.77 MAPT (0.79) MEN1KMT2AMAPTALDH1A1POLB
SCHEMBL2993239 0.77 MEN1 (1.00) MEN1KMT2AMAPTALDH1A1POLB
SCHEMBL13170460 0.77 DUSP22 (0.52) MEN1KMT2AMAPTALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10501413-B2 Inhibitors of the Notch transcriptional activation complex and methods for use of the same UNIVERSITY OF MIAMI (US) 2019-12-10 US disclosed
US-20180086700-A1 INHIBITORS OF THE NOTCH TRANSCRIPTIONAL ACTIVATION COMPLEX AND METHODS FOR USE OF THE SAME NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2018-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10501413-B2 Inhibitors of the Notch transcriptional activation complex and methods for use of the same NOTCH1, CBFB, HES1 MEN1 846/4885KMT2A 470/4885MAPT 3938/4885
US-20180086700-A1 INHIBITORS OF THE NOTCH TRANSCRIPTIONAL ACTIVATION COMPLEX AND METHODS FOR USE OF THE SAME NOTCH1, CBFB, HES1 MEN1 846/4885KMT2A 470/4885MAPT 3938/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.